BSA nanoparticle loaded atorvastatin calcium - A new facet for an old drug

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Sripriyalakshmi, S ^a   Anjali, C H ^a   George Priya Doss, C ^b   Rajith, B ^b   Ravindran, Aswathy ^a  

^a SASTRA UNIVERSITY   (India)

^b VIT UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; BOVINE SERUM ALBUMIN; CAVEOLIN; GLUTARALDEHYDE; NANOPARTICLE; ANTINEOPLASTIC AGENT; HEPTANOIC ACID DERIVATIVE; HYPOCHOLESTEROLEMIC AGENT; PYRROLE DERIVATIVE; REACTIVE OXYGEN METABOLITE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL TRANSPORT; CELL UPTAKE; CELL VIABILITY; CONTROLLED STUDY; CROSS LINKING; CYTOTOXICITY; DRUG CONCENTRATION; DRUG RELEASE; ENCAPSULATION; ENDOCYTOSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; ADULT; ANIMAL; BOVINAE; CELL SURVIVAL; CHEMISTRY; CONFOCAL MICROSCOPY; DRUG EFFECTS; HEMOLYSIS; INFRARED SPECTROSCOPY; KINETICS; METABOLISM; MOLECULAR DOCKING; PANCREAS TUMOR; PATHOLOGY; SCANNING ELECTRON MICROSCOPY; SPECTROFLUOROMETRY; TIME; TUMOR CELL LINE; ULTRASTRUCTURE;

ADULT; ANIMALS; ANTICHOLESTEREMIC AGENTS; ANTINEOPLASTIC AGENTS; CATTLE; CELL LINE, TUMOR; CELL SURVIVAL; HEMOLYSIS; HEPTANOIC ACIDS; HUMANS; KINETICS; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, SCANNING; MOLECULAR DOCKING SIMULATION; NANOPARTICLES; PANCREATIC NEOPLASMS; PYRROLES; REACTIVE OXYGEN SPECIES; SERUM ALBUMIN, BOVINE; SPECTROMETRY, FLUORESCENCE; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TIME FACTORS;

EID: 84895446373     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0086317     Document Type: Article

References (33)

1. Olivia F, Zahia H,Pierre J, Marie(2008) Statin induced Inhibition of 3-Hydroxy-3-Methyl Glutaryl Coenzyme A Reductase Sensitizes Human Osteosarcoma Cells to Anticancer Drugs. JPET 325:595-600.
2. Aznar S, Lacal JC (2001) Rho signals to cell growth and apoptosis. Cancer Lett 165:1-10. (Pubitemid 32206651)
3. Fromigue O, Hay E, Modrowski D, Bouvet S, Jacquel A, et al. (2006) RhoA GTPase inactivation by statins induces osteosarcoma cell apoptosis by inhibiting p42/p44-MAPKs-Bcl-2 signaling independently of BMP-2 and cell differentiation. Cell Death Differ 13:1845-1856. (Pubitemid 44542398)
4. Sieczkowski E, Lehner C, Ambros PF, Hohenegger M (2010) Double impact on p-glycoprotein by statins enhances doxorubicin cytotoxicity in human neuroblastoma cells. Int J Cancer 126(9): 2025-35
5. Doshi N, Mitragotri S (2009) Designer biomaterials for nanomedicine. Adv Func Mat 19: 3843-54.
6. Irache JM, Merodio M, Arnedo A, Camapanero MA, Mirshahi M, et al. (2005) Albumin nanoparticles for the intravitreal delivery of anticytomegaloviral drugs. Mini-Reviews in Medicinal Chemistry. 5(3): 293-305. (Pubitemid 40331045)
7. Weber C, Coester C, Kreuter J, Langer K (2000) Desolvation process and surface characterisation of protein nanoparticles. Intern Journ of Pharm. 194(1): 91-102.
8. Brigger I, Dubernet C, Couvreur P (2009) Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliv Rev 54(5): 631-651.
9. Jiang W, Kim BY, Rutka JT, Chan WC (2007) Advances and challenges of nanotechnology-based drug delivery systems. Expert Opin Drug Deliv. 4(6): 621-633. (Pubitemid 350199200)
10. Marty JJ, Oppenheimer RC, Speiser P (1978) Nanoparticles - a new colloidal drug delivery system. Pharm Acta Helv 53: 17-23.
11. Marta M, Amaia A, Renedo MJ, Juan MI (2001) Ganciclovir-loaded albumin nanoparticles: characterization and in vitro release properties. Euro Journ of Pharm Sci 12: 251-259.
12. Majorek KA, Porebski PJ, Dayal A, Zimmerman MD, Jablonska K(2012)Struc-)Structural and immunologic characterization of bovine, horse, and rabbit serum albumins. Mol Immunol 52(3-4): 174-82.
13. Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, et al. (1998) Automated docking using a Lamarckian genetic algorithm and empirical binding free energy function. J Comput Chem 19: 1639-1662. (Pubitemid 128590223)
14. Sanner MF (1999) Python: A programming language for software integration and development. J Mol Graph Model 17: 57-61.
15. Wallace AC, Laskowski RA, Thornton JM (1995) LIGPLOT: A program to generate schematic diagrams of protein-ligand interactions. Protein Eng 8: 127-134.
16. DeLano WL (2002) The PyMOL Molecular Graphics System. DeLano Scientific, San Carlos, CA, USA.
17. Lin W, Coombes AGA, Davies MC, Davis SS, Illum L (1993) Preparation of sub-100 nm human serum albumin nanoparticles using a pH-coacervation method. J Drug Target 1: 237-243.
18. Langer K, Balthasara S, Vogel V, Dinauer N, Briesen HV, et al. (2003) Optimization of the preparation process for human serum albumin (HSA) nanoparticles. International Journal of Pharmaceutics. 257:169-180. (Pubitemid 36507043)
19. Andre EN, Lutz M, Darrell V, Tian X, Eric MV, et al. (2009) Understanding biophysicochemical interactions at the nano-bio interface. Nature mat (8): 543-557.
20. Jhonsi MA, Kathiravan A, Renganathan R (2009) Spectroscopic studies on the interaction of colloidal capped CdS nanoparticles with bovine serum albumin. Colloids and Surfaces B: Biointerfaces 72:167-172.
21. Sankar J, Shalini G, Sasanka D,Nikhil G (2012) Exploring structural change of protein bovine serum albumin by external perturbation using extrinsic fluorescence probe: spectroscopic measurement, molecular docking and molecular dynamics simulation. Photochem Photobiol Sci 11: 323.
22. Wang YB, Wang JC, Meng M, Hua Z, Qiang Z (2010)Preparation and evaluation of docetaxel-loaded albumin nanoparticles for intravenous administration. Journ of Chin Pharm Sci 19: 214-222.
23. Eom HJ, Choi J (2010) p38 MAPK activation, DNA damage, cell cycle arrest and apoptosis as mechanisms of toxicity of silver nanoparticles in Jurkat T cells. Environ Sci Technol 44: 8337-8342.
24. Ruizendaal L, Bhattacharjee S, Pournazari K, Rosso-Vasic M, Haan LHJ, et al. (2009) Synthesis and cytotoxicity of silicon nanoparticles with covalently attached organic monolayers. Nanotoxicology 3: 339-347.
25. Gao H, Shi W, Freund LB (2005) Mechanics of receptor-mediated endocytosis. Proc Natl Acad Sci USA 102: 9469-9474. (Pubitemid 40981705)
26. Jithan AV, Madhavi M, Prabhakar K (2011) Preparation and characterization of albumin nanoparticles encapsulating curcumin intended for the treatment of breast cancer. Int J Pharm Investig 1(2): 119-125.
27. Joanna R, Volker O, Zuhorn IS, Dick H (2004) Size-dependent internalization of particles via the pathways of clathrin and caveolae-mediated endocytosis. Biochem J 377: 159-169. (Pubitemid 38114443)
28. Felix K (2008) Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles. Journal of Controlled Release 132: 171-183.
29. Moriyama Y, Ohta D, Hachiya K, Mitsui Y, Takeda K (1996) Fluorescence behavior of tryptophan residues of bovine and human serum albumins in ionic surfactant solutions: A comparative study of the two and one tryptophan(s) of bovine and human albumins. J Protein Chem 15: 265-272. (Pubitemid 26179086)
30. Carter DC, He XM (1990) Atomic structure and chemistry of human serum albumin. Science 249: 302-303. (Pubitemid 20232094)
31. Sardar PS, Samanta S, Maity SS, Dasgupta S, Ghosh S (2008) Energy transfer photophysics from serum albumin to sequestered 3-hydroxy 2- naphthoic acid, an excited state intramolecular proton transfer probe. J Phys Chem B 112:3451-3461.
32. Jana S, Ghosh S, Dalapati S, Guchhait N (2012) Exploring structural change of protein bovine serum albumin by external perturbation using extrinsic fluorescence probe: spectroscopic measurement, molecular docking and molecular dynamics simulation. Photochem Photobiol Sci 11:323-32.
33. Joshi P, Chakraborty S, Dey S, Shanker V, Ansari ZA, et al.(2011) Binding of chloroquine-conjugated gold nanoparticles with bovine serum albumin 355(2): 402-409